Qiagen Shares Reach 52-Week High | GenomeWeb

Shares in Qiagen hit a 52-week high of $15.58 earlier this week before closing at $14.91 on Tuesday, up 8.4 percent for the tracking period. Shares in Qiagen, which led gains among all issues in the BCW Index, have risen 32.5 percent over the past month.

Meanwhile, Bio-Rad shares dropped 11.9 percent for the week, leading all decliners. Last week, the firm reported that its fourth-quarter profit and revenue were hit by costs associated with a legal dispute (see feature).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.